We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Incidence Rate of Breast Cancer in Young Women—Reply

Rebecca H. Johnson, MD; Frank L. Chien, BA; Archie Bleyer, MD
JAMA. 2013;309(23):2433. doi:10.1001/jama.2013.6464.
Text Size: A A A
Published online


In Reply: Drs Hou and Huo suggest that we should correct for missing data on receptor status in the SEER database. Using the method1 cited by Hou and Huo, we calculated that for 25- to 39-year-old women diagnosed with distant stage breast cancer during 1992-2009, the APC after correcting for missing values was 3.85 (95% CI, 1.61 to 6.15; P = .002) for ER+PR+ disease and 3.32 (95% CI, 0.81 to 5.90; P = .01) for ER+PR− disease. The APCs for ER−PR+ and ER−PR− were −6.24 (95% CI, −10.53 to −1.74; P = .01) and 2.01 (95% CI, 0.44 to 3.60; P = .02), respectively. Thus, we again find that the incidence of ER+PR+, ER+PR−, and ER−PR− disease in young women is increasing. The ER−PR+ receptor status was initially nonsignificant but decreased with significance after the correction. We agree that divergent trends exist between the different receptor subtypes, but ER−PR− disease is increasing as are both subtypes of ER+ disease.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




June 19, 2013
Ningqi Hou, MHS, PhD; Dezheng Huo, MD, PhD
JAMA. 2013;309(23):2433. doi:10.1001/jama.2013.6456.
June 19, 2013
Parisa Tehranifar, DrPH; Tomi F. Akinyemiju, PhD; Mary Beth Terry, PhD
JAMA. 2013;309(23):2433. doi:10.1001/jama.2013.6461.
June 19, 2013
Mark R. Goldstein, MD; Luca Mascitelli, MD
JAMA. 2013;309(23):2433. doi:10.1001/jama.2013.6447.
June 19, 2013
Daniel W. Cramer, MD, ScD; Olivera J. Finn, PhD
JAMA. 2013;309(23):2433. doi:10.1001/jama.2013.6450.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...